• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational

  • MNC Asc-Glaxo
  • BSE Code : 195.0
  • ISIN : INE159A01016
3,298.60 35 (1.08%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    3,237.90

  • Today’s High

    3,359.00

  • Open

    3,249.90

  • Perv Close

    3,263.40

  • 52W Low

    1,921.00

  • 52W High

    3,398.00

Key Indicators

  • P/E(TTM)

    60.96

  • Mar.Cap (₹Cr.)

    55,880.27

  • Div & Yield %

    2.37

  • Book Value(₹)

    115.06

  • Debt-Equity Ratio

    1.08

  • AGM Date

    30-May-2025

  • EPS

    54.05

  • P/E Ratio

    60.96

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    55,880.27

  • RONW (%)

    37.32

  • ROCE (%)

    44.97

Score Board

  • Equity (₹ in Cr.)

    169.41

  • BV (₹)

    115.10

  • Sales( ₹ in Cr.)

    3,723.49

  • NP (in Cr.)

    915.61

  • NP Var(%)

    41.0

  • Div%

    780.0

  • CPS (₹)

    58.00

  • EPS (₹)

    54.00

  • Traded Value (₹ in Lakhs)

    55,819.29

  • 52 Week High

    3,398.00

  • 52 Week Low

    1,921.00

  • Price BSE

    3295.0

  • Price NSE

    3,299.00

  • Market Capital( in Cr.)

    55,819.29

  • P/C Ratio

    56.80

  • P/E Ratio

    61.00

  • Price Vs.BV

    54.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Other Income 143.17 114.96 1,423.27 217.71 624.37 149.56
Stock Adjustments 69.64 -67.25 -13.83 26.12 35.43 -25.57
Total Income 3,620.06 3,264.05 4,626.95 3,164.31 3,884.48 3,252.52
EXPENDITURE :            
Raw Materials 1,358.07 1,182.78 1,281.91 1,275.49 1,343.30 1,327.96
Power and Fuel Cost 29.64 29.60 27.83 26.08 33.36 27.94
Employee Cost 624.39 594.99 610.23 616.16 628.55 537.20
Other Manufacturing Expenses 113.61 99.05 120.14 110.59 107.88 115.19
Selling and Administration Expenses 374.71 370.30 343.57 242.00 376.68 381.32
Miscellaneous Expenses 239.12 84.32 85.69 287.75 983.19 150.08
Employee Benefit Expenses 624.39 594.99 610.23 616.16 628.55 537.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,739.54 2,361.04 2,469.38 2,558.07 3,472.96 2,539.68
Operating Profit 880.52 903.01 2,157.57 606.24 411.52 712.85
Interest 1.80 1.81 1.99 3.53 6.34 0.55
Gross Profit 878.72 901.20 2,155.58 602.71 405.18 712.30
Depreciation 69.68 65.77 68.19 78.60 82.68 48.59
Profit Before Tax 809.04 835.43 2,087.39 524.11 322.50 663.71
Current Tax 235.71 246.05 407.36 158.67 260.17 192.82
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -11.36 -18.37 -10.49 7.87 -47.72 45.52
Reported Net Profit 584.69 607.75 1,690.53 357.57 110.05 425.36
Extraordinary Items -66.58 21.05 11.18 -117.79 -87.09 4.04
Adjusted Net Profit 651.27 586.70 1,679.35 475.36 197.14 421.32
Adjustment below Net Profit -21.25 -17.08 -11.05 0.00 -73.62 -64.12
P & L Balance brought forward 828.12 1,745.02 562.71 882.77 1,177.99 1,113.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 542.10 1,524.66 508.22 677.62 338.81 296.46
P & L Balance carried down 849.46 811.03 1,733.98 562.71 875.62 1,177.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 320.00 320.00 900.00 300.00 400.00 200.00
Dividend Per Share(Rs) 32.00 32.00 90.00 30.00 40.00 20.00
Earnings Per Share-Unit Curr 34.51 35.88 99.79 21.11 6.50 25.11
Earnings Per Share(Adj)-Unit Curr 34.51 35.88 99.79 21.11 6.50 25.11
Book Value 105.31 103.48 158.06 88.37 108.62 126.47
Book Value(Adj)-Unit Curr 105.31 103.48 158.06 88.37 108.62 126.47

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,054,524 75.00 127,054,524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,054,524 75.00 127,054,524 4
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 6,304 0.00 6,304 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18,328 0.01 11,364 18
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,654,731 4.52 7,654,693 255
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,366,548 2.58 4,366,548 11
Mutual Funds / UTI 8,752,415 5.17 8,738,995 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 53,294 0.03 40,410 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,851,620 12.31 20,818,314 340
2] Non Institution
Bodies Corporate 1,124,761 0.66 1,108,973 882
Clearing Members 5,494 0.00 5,494 5
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 820,498 0.48 811,343 3,901
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 437,378 0.26 437,378 2,272
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 680,250 0.40 680,250 14
Individuals holding nominal share capital up to Rs. 1 lakh 17,276,256 10.20 16,081,417 114,440
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 92,849 0.05 92,849 25
Others 1,061,804 0.63 1,061,804 1
Sub Total 21,499,890 12.69 20,280,108 121,541
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 169,406,034 100.00 168,152,946 121,885

Company Background

Glaxosmithkline Pharmaceuticals LtdPharmaceuticals - Multinational

  • Glaxosmithkline Pharmaceuticals Ltd
  • BSE Code : 195.0
  • ISIN : INE159A01016

  • Incorporation Year

    1924

  • Registered Office

    GSK House
    Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24959595

  • FAX

    91-022-24959494

  • Chairman

    Renu S Karnad

  • Managing Director

    Bhushan Akshikar

  • Company Secretary

    A A Nadkarni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Novartis India 1,041.65 396.75 335.07 25.49 15.57
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92